How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by chandru – India, 2018-05-27 23:26 (1835 d 15:21 ago) – Posting: # 18819
Views: 2,505

Hi Ohlbe,

Is it ok to evaluate working solution stability according to FDA guidance May 2018 at LQC and HQC level.

As they have spoken about stock solution stability which has to be done at LQC and HQC level. Does it apply for working solution stability?


Complete thread:

UA Flag
 Admin contact
22,618 posts in 4,741 threads, 1,611 registered users;
30 visitors (1 registered, 29 guests [including 3 identified bots]).
Forum time: 14:47 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz